Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Michael Cullen
FOU | Founder | 78 | 21/09/11 |
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 16/07/20 |
Susan Horvath
DFI | Director of Finance/CFO | 65 | 17/04/18 |
Tammy Groene
COO | Chief Operating Officer | - | 01/04/12 |
Chief Tech/Sci/R&D Officer | - | 01/06/22 | |
Rachel Bragg
PRN | Corporate Officer/Principal | - | 01/06/21 |
- | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 16/07/20 |
Director/Board Member | 63 | 30/09/15 | |
Michael Cullen
FOU | Founder | 78 | 21/09/11 |
Jeffrey Jacob
BRD | Director/Board Member | 62 | 15/06/22 |
Arthur Fratamico
BRD | Director/Board Member | 58 | 16/12/19 |
Dan Donovan
BRD | Director/Board Member | 59 | 15/06/22 |
Donald Schemel
BRD | Director/Board Member | 68 | 04/09/15 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 4 854 931 | 4 854 791 ( 100,00 %) | 70 ( 0,001442 %) | 100,00 % |
Coordonnées société
Panbela Therapeutics, Inc.
712 Vista Boulevard Suite 305
55387, Waconia
+952 479 1196
http://www.panbela.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+14,16 % | 3 161 Md | |
+10,84 % | 87,62 Md | |
+7,05 % | 79,59 Md | |
-12,83 % | 54,14 Md | |
+23,97 % | 48,15 Md | |
+33,07 % | 47,69 Md | |
-24,83 % | 46,81 Md | |
+80,05 % | 42 Md | |
-5,67 % | 25,77 Md |